About this trial
Currently used biopsy devices do not predictably obtain full cores of tissue and the tissue obtained is often fragmented and disrupted making it difficult for pathological review. This post-market study will assess the utility of the SUREcore biopsy needle and the coreCARE specimen retrieval device versus a standard of care biopsy needle and the typical tissue container used in urology offices and clinics today.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult male scheduled for prostate biopsy
Able to provide informed consent
Able and willing to provide verbal assessment of his condition 5 days post-procedure
Disqualifiers
Unwilling to provide consent
Trial design
Parallel
Treatments tested in this trial
Prostate biopsy needle
DeviceProstate tissue biopsy with a biopsy needle
Treatment groups
Trial outcomes
Primary outcomes
Procedure Success
Percentage of tissue samples collected that are suitable for pathological review
Core length of tissue in the sample
Quantity of Tissue Samples Collected
weight of tissue in the sample
Quantity of Tissue Samples Collected
Tissue Sample Preparation
Time required to prepare the tissue samples for pathological review
Secondary outcomes
Ease of use of the biopsy needle
Utility of the biopsy needle measured with a Likert scale of 1 to 5
Sponsors and contacts
Click on the lead sponsor to view all of their trials.